CS1007486A1 - Platinum cytostatic - Google Patents

Platinum cytostatic

Info

Publication number
CS1007486A1
CS1007486A1 CS8610074A CS1007486A CS1007486A1 CS 1007486 A1 CS1007486 A1 CS 1007486A1 CS 8610074 A CS8610074 A CS 8610074A CS 1007486 A CS1007486 A CS 1007486A CS 1007486 A1 CS1007486 A1 CS 1007486A1
Authority
CS
Czechoslovakia
Prior art keywords
platinum
cis
cytostatic agent
cytostatic
platinum cytostatic
Prior art date
Application number
CS8610074A
Other languages
English (en)
Other versions
CS269719B1 (en
Inventor
Frantisek Ing Kiss
Ivanka Rndr Zavodna
Jiri Ing Novotny
Eduard Rndr Hajek
Monika Ing Bohuminska
Ludmila Marcikova
Zdenka Uhrova
Jindrich Ing Borak
Jaroslav Ing Salamoun
Original Assignee
Kiss Frantisek
Z Ivanka Rndr
Novotny Jiri
Hajek Eduard
Bohuminska Monika
Ludmila Marcikova
Zdenka Uhrova
Borak Jindrich
Jaroslav Ing Salamoun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5447844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CS1007486(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kiss Frantisek, Z Ivanka Rndr, Novotny Jiri, Hajek Eduard, Bohuminska Monika, Ludmila Marcikova, Zdenka Uhrova, Borak Jindrich, Jaroslav Ing Salamoun filed Critical Kiss Frantisek
Priority to CS8610074A priority Critical patent/CS269719B1/cs
Priority to FI875729A priority patent/FI88165C/fi
Priority to DE8787119339T priority patent/DE3771057D1/de
Priority to AT87119339T priority patent/ATE64740T1/de
Priority to ES198787119339T priority patent/ES2040240T3/es
Priority to EP87119339A priority patent/EP0275559B1/en
Priority to JP63000051A priority patent/JPS63239292A/ja
Priority to BG82504A priority patent/BG50995A1/bg
Priority to IL85029A priority patent/IL85029A/xx
Priority to DD31210288A priority patent/DD289651A7/xx
Publication of CS1007486A1 publication Critical patent/CS1007486A1/cs
Publication of CS269719B1 publication Critical patent/CS269719B1/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
  • Developing Agents For Electrophotography (AREA)
CS8610074A 1986-12-29 1986-12-29 Platinum cytostatic CS269719B1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CS8610074A CS269719B1 (en) 1986-12-29 1986-12-29 Platinum cytostatic
FI875729A FI88165C (fi) 1986-12-29 1987-12-28 Foerfarande foer framstaellning av cis-diammin-1,1-cyklobutandikarboxylat-platina(ii)komplex
EP87119339A EP0275559B1 (en) 1986-12-29 1987-12-29 Platinum cytostatic agent
ES198787119339T ES2040240T3 (es) 1986-12-29 1987-12-29 Agente citostatico de platino.
AT87119339T ATE64740T1 (de) 1986-12-29 1987-12-29 Platin enthaltender cytostatischer wirkstoff.
DE8787119339T DE3771057D1 (de) 1986-12-29 1987-12-29 Platin enthaltender cytostatischer wirkstoff.
JP63000051A JPS63239292A (ja) 1986-12-29 1988-01-04 白金細胞毒性剤及びその製造方法
BG82504A BG50995A1 (en) 1986-12-29 1988-01-04 Platinum cytostatic
IL85029A IL85029A (en) 1986-12-29 1988-01-05 Microcrystalline cis diammineplatinum(ii)complex of 1,1-cyclobutanedicarboxylic acid,its preparation and cytostatic pharmaceutical compositions containing it
DD31210288A DD289651A7 (de) 1986-12-29 1988-01-11 Platin-zytostatikum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS8610074A CS269719B1 (en) 1986-12-29 1986-12-29 Platinum cytostatic

Publications (2)

Publication Number Publication Date
CS1007486A1 true CS1007486A1 (en) 1989-10-13
CS269719B1 CS269719B1 (en) 1990-05-14

Family

ID=5447844

Family Applications (1)

Application Number Title Priority Date Filing Date
CS8610074A CS269719B1 (en) 1986-12-29 1986-12-29 Platinum cytostatic

Country Status (9)

Country Link
EP (1) EP0275559B1 (cs)
JP (1) JPS63239292A (cs)
AT (1) ATE64740T1 (cs)
BG (1) BG50995A1 (cs)
CS (1) CS269719B1 (cs)
DE (1) DE3771057D1 (cs)
ES (1) ES2040240T3 (cs)
FI (1) FI88165C (cs)
IL (1) IL85029A (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8901433A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Carboplatinpreparaat.
JPH06287021A (ja) * 1992-04-22 1994-10-11 Tanaka Kikinzoku Kogyo Kk 光学活性な白金錯化合物の光学的分割方法
ES2160117T3 (es) * 1994-02-07 2001-11-01 Pliva Pharmaceutical Industry Composicion farmaceutica antitumoral a base de carboplatino, y su procedimiento de produccion.
CZ292170B6 (cs) * 1998-08-14 2003-08-13 Pliva-Lachema A.S. Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
CN1121380C (zh) * 2000-03-03 2003-09-17 北京兴大豪斯科技有限公司 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物
RU2219183C2 (ru) * 2000-03-03 2003-12-20 Зукин ЯН Производное комплекса удвоенная дикарбоновая кислота-диаминоплатина, способ его получения, противоопухолевая фармацевтическая композиция и использование этого производного
DE10306761B9 (de) * 2003-02-17 2004-12-23 Völkl, Klaus Peter, Dr. Verfahren zur Herstellung von sterilen pharmazeutischen Wirkstoffen
RS62412B1 (sr) 2015-12-09 2021-10-29 Univ Wien Med Jedinjenja platine funkcionalizovana sa monomaleimidom za terapiju raka

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588505A5 (cs) * 1972-06-08 1977-06-15 Research Corp
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4696918A (en) * 1984-11-02 1987-09-29 Johnson Matthey Public Limited Company Solubilized platinum compound

Also Published As

Publication number Publication date
FI88165C (fi) 1993-04-13
FI875729L (fi) 1988-06-30
IL85029A0 (en) 1988-06-30
FI875729A0 (fi) 1987-12-28
BG50995A1 (en) 1993-01-15
JPS63239292A (ja) 1988-10-05
DE3771057D1 (de) 1991-08-01
ES2040240T3 (es) 1993-10-16
EP0275559A1 (en) 1988-07-27
EP0275559B1 (en) 1991-06-26
CS269719B1 (en) 1990-05-14
ATE64740T1 (de) 1991-07-15
IL85029A (en) 1992-06-21
FI88165B (fi) 1992-12-31

Similar Documents

Publication Publication Date Title
CA2041260A1 (en) Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
CA2124932A1 (en) Sex steroid activity inhibitors
MY115339A (en) Compositions containing micronized nebivolol
TW229208B (cs)
ZA844585B (en) 2-pyrimidinyl-1-piperazine derivatives,processes for their preparation and medicaments containing them
EG18379A (en) Novel pharmacological compounds
JO1502B1 (en) New pharmacy vehicles
DE68911742D1 (de) Substituierte flavonoide Verbindungen, ihre Salze, ihre Herstellung und die enthaltende Arnzeizusammensetzungen.
GEP19971265B (en) Substituted sulphonamides,, the substituted cyclic amines in the form of intermediate compounds for reception of the substituted sulphonamides and the pharmaceutical composition on the basis of the substituted sulphonamides displaying activity towards thromboxane receptors
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
DE69526353D1 (de) Immunologische aktivität der rhamnolipide
IL107870A0 (en) Pharmaceutical compositions having antidepressant activity comprising pramipexol
IL85029A0 (en) Platinum cytostatic agent
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
ES473754A1 (es) Procedimiento de preparacion de composiciones farmaceuticas a base de nuevas w-tiopropinamidas, y de sus sales con una base mineral y organica
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
DE3780191D1 (de) Octahydroindolizine analgesica und 7-keto-zwischenprodukte.
FR2355846A1 (fr) Esters de penicillines utilisables comme medicaments
EP0043976A3 (en) Anti-tumor agent
ES8207542A1 (es) Un procedimiento para la preparacion de 1rs,4rs,5rs-4-(4,8 dimetil-5-hidroxi-7-nomen-1-1-il)-4-metil-3,8-dioxabiciclo(3.2.1)octano-1.aletico.
JO1711B1 (en) Therapeutic agents
SE8704049D0 (sv) Novel pharmacological compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)